FDA and National Alliance for Hispanic Health Release Genes, Culture, and Health Report
Washington, DC (PRWEB) February 26, 2015 -- Today, the National Alliance for Hispanic Health, in collaboration with the U.S. Food and Drug Administration, released the report Genes, Culture, and Health: Ensuring the Best Health Outcomes for All. The report reviewed available research and found that while dramatic advances are being made in genetics and their clinical applications, the promise of personalized medicine is not being realized by all.
“A lack of inclusion in genetic research is creating a genomic divide putting the frontiers of science and medicine at risk. Without a dramatic reversal in the quality of genetic studies, the benefits of personalized medicine will not be realized by all,” said Dr. Jane L. Delgado, President and CEO of the Alliance.
“Ensuring that all patients benefit from discoveries in genetic science and personalized medicine is critical to our nation’s health. The FDA is committed to working with diverse partners on the road forward for access to the best science and treatment,” said Dr. Jonca Bull, Director of the U.S. Food and Drug Administration’s (FDA) Office of Minority Health. Dr. Bull added, “The report issued today is an important update on the status of genetic research and personalized medicine. It calls on all of us to do a better job on inclusion to improve our understanding of how medical products will work in the populations intended to use them.”
Among the key findings of the report released today —
• Attention to issues of inclusion and access will advance personalized medicine by driving genetic discovery that benefits all. Advances in personalized medicine, from determining the most effective medicine and dose to new biologic therapies tailored to the individual, require inclusion of diverse populations in research.
• Major racial and ethnic U.S. populations, as well as women, are underrepresented in genetic studies. As of 2011, only 4% of genome wide association studies included persons of non-European descent.
• Without diversity in study populations, genetic variants important to disease and therapy responses may go undiscovered. Variants found in less than 5% of people may be the most significant to understanding disease risk and response to particular therapies.
Downloadable copies of the Genes, Culture, and Health report and key findings are available online at the Alliance website (http://www.hispanichealth.org) and consumers can get information on how to have a discussion with their health provider on the role of genetics in their and their family’s health by calling the Alliance’s bilingual Su Familia Helpline at 1-866-783-2645.
###
The National Alliance for Hispanic Health is the nation's foremost science-based source of information and trusted non-partisan advocate for the best health outcomes for all. The Alliance represents thousands of Hispanic health providers across the nation providing services to more than 15 million each year. For more information, visit http://www.hispanichealth.org, call the Alliance’s Su Familia Helpline at 1-866-783-2645, or find us on Facebook at healthyamericas or on Twitter at health4americas.
Adolph Falcon, National Alliance For Hispanic Health, +1 202-797-4341, [email protected]
Share this article